SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000886163-20-000101
Filing Date
2020-09-10
Accepted
2020-09-10 16:43:44
Documents
18
Period of Report
2020-09-08
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K lgnd-20200908.htm   iXBRL 8-K 46141
2 EX-10.1 a101ligandxcellaagreem.htm EX-10.1 713540
3 EX-10.2 a102ligandtaurusagreem.htm EX-10.2 638625
4 EX-10.3 a103ligandtauruscvragr.htm EX-10.3 117178
5 EX-10.4 a104ligandtaurusminota.htm EX-10.4 332099
  Complete submission text file 0000886163-20-000101.txt   2265043

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lgnd-20200908.xsd EX-101.SCH 2430
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT lgnd-20200908_cal.xml EX-101.CAL 718
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT lgnd-20200908_def.xml EX-101.DEF 1655
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lgnd-20200908_lab.xml EX-101.LAB 24270
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lgnd-20200908_pre.xml EX-101.PRE 12654
11 EXTRACTED XBRL INSTANCE DOCUMENT lgnd-20200908_htm.xml XML 10767
Mailing Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121
Business Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121 858-550-7500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

IRS No.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33093 | Film No.: 201169085
SIC: 2834 Pharmaceutical Preparations